ChipokiaTech news, without the noise
← All stories

Eating disorders are on the rise. GLP-1s could make things worse.

GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders. A new report suggests that the global incidence…

Preview courtesy of MIT Technology Review. The full article opens on their site.

More from MIT Technology Review